Entorhinal cortex tau PET

Biomarker

2 papers4 findings

  • Humans2

Effects

1

Preclinical Alzheimer Cognitive Composite

downin humans1

1 study
  1. Entorhinal cortex tau PET impairs Preclinical Alzheimer Cognitive Composite in humans.

    “In both cohorts, EC tau was associated with worse PACC performance in both NHB and NHW”

    Humansin cognitively unimpaired older adults (both NHB and NHW in ADNI and US POINTER)entorhinal cortex

    Evaluation of Alzheimer's disease biomarkers and cognition in non‐Hispanic Black and non‐Hispanic White participants in ADNI and US POINTER Imaging

    AAIC 2025 abstract25 Dec 2025

More on Preclinical Alzheimer Cognitive Composite

Associations

3

Amyloid beta PET

upin humans1

1 study
  1. Amyloid beta PET is associated with entorhinal cortex tau PET in humans.

    “In US POINTER, the positive Aβ‐EC tau relationship was observed in both ethnoracial groups”

    Humansin US POINTER (both NHB and NHW) and ADNI (NHW only)entorhinal cortex

    Evaluation of Alzheimer's disease biomarkers and cognition in non‐Hispanic Black and non‐Hispanic White participants in ADNI and US POINTER Imaging

    AAIC 2025 abstract25 Dec 2025

More on Amyloid beta PET

p-Tau217

upin humans1

1 study
  1. p-Tau217 predicts entorhinal cortex tau PET in humans (AUROC 0.81 vs 0.70).

    “MSD p-tau217: AUROC, 0.81 vs 0.70; P = .04”

    Humanscognitively unimpaired participantsplasman = 177

    Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes

    JAMA neurology1 Sep 2021

More on p-Tau217

P-TAU181

upin humans1

1 study
  1. P-TAU181 predicts entorhinal cortex tau PET in humans (AUROC 0.80 vs 0.70).

    “both MSD p-tau181 and MSD p-tau217 more accurately predicted abnormal entorhinal cortex tau PET than Simoa p-tau181 (MSD p-tau181: AUROC, 0.80 vs 0.70; P = .046”

    Humanscognitively unimpaired participantsplasman = 177

    Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes

    JAMA neurology1 Sep 2021

More on P-TAU181

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months